Manufacturers Life Insurance Company, The Durect Corp Transaction History

Manufacturers Life Insurance Company, The

$108 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.38 - $0.64 $16,533 - $27,845	-43,508 Closed	0 $0
Q1 2022 Aug 11, 2023	BUY	$0.55 - $0.98 $23,929 - $42,637	43,508 New	43,508 $29,000
Q1 2022 May 20, 2022	SELL	$0.55 - $0.98 $2,316 - $4,126	-4,211 Reduced 8.82%	43,508 $29,000
Q4 2021 Feb 16, 2022	SELL	$0.9 - $1.31 $20,014 - $29,131	-22,238 Reduced 31.79%	47,719 $47,000
Q3 2021 Nov 12, 2021	SELL	$1.21 - $1.61 $92,258 - $122,757	-76,247 Reduced 52.15%	69,957 $90,000
Q2 2021 Aug 12, 2021	BUY	$1.6 - $2.02 $19,795 - $24,991	12,372 Added 9.24%	146,204 $238,000
Q1 2021 May 03, 2021	BUY	$1.86 - $2.87 $12,532 - $19,338	6,738 Added 5.3%	133,832 $265,000
Q4 2020 Feb 12, 2021	BUY	$1.65 - $2.43 $11,731 - $17,277	7,110 Added 5.93%	127,094 $263,000
Q2 2020 Aug 10, 2020	BUY	$1.33 - $2.76 $159,578 - $331,155	119,984 New	119,984 $300,000
Q2 2019 Aug 14, 2019	SELL	$0.51 - $0.86 $51,062 - $86,105	-100,123 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$0.51 - $0.82 $9,423 - $15,151	18,478 Added 22.63%	100,123 $62,000
Q4 2018 Feb 14, 2019	BUY	$0.48 - $1.1 $125 - $287	261 Added 0.32%	81,645 $40,000
Q3 2018 Nov 14, 2018	SELL	$1.06 - $1.69 $46,582 - $74,268	-43,946 Reduced 35.06%	81,384 $90,000
Q2 2018 Aug 14, 2018	BUY	$1.56 - $2.51 $22,492 - $36,189	14,418 Added 13.0%	125,330 $195,000
Q1 2018 May 15, 2018	SELL	$0.91 - $2.24 $14,926 - $36,742	-16,403 Reduced 12.88%	110,912 $238,000
Q4 2017 Feb 08, 2018	BUY	$0.78 - $2.1 $8,763 - $23,593	11,235 Added 9.68%	127,315 $117,000
Q3 2017 Nov 14, 2017	BUY	$1.55 - $1.82 $179,924 - $211,265	116,080	116,080 $206,000

Others Institutions Holding DRRX

# of Institutions

Shares Held

593K

Call Options Held

Put Options Held

View Full List

About DURECT CORP

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $173M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

More about DRRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account